CSX vs GALT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSX is a Buy and GALT is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CSX’s FA Score shows that 0 FA rating(s) are green whileGALT’s FA Score has 0 green FA rating(s).
- CSX’s FA Score: 0 green, 5 red.
- GALT’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CSX’s TA Score shows that 4 TA indicator(s) are bullish while GALT’s TA Score has 5 bullish TA indicator(s).
- CSX’s TA Score: 4 bullish, 4 bearish.
- GALT’s TA Score: 5 bullish, 4 bearish.
Price Growth
CSX (@Railroads) experienced а +6.46% price change this week, while GALT (@Biotechnology) price change was +6.11% for the same time period.
The average weekly price growth across all stocks in the @Railroads industry was +2.33%. For the same industry, the average monthly price growth was +7.09%, and the average quarterly price growth was -4.30%.
The average weekly price growth across all stocks in the @Biotechnology industry was -3.48%. For the same industry, the average monthly price growth was +10.12%, and the average quarterly price growth was -9.68%.
Reported Earning Dates
CSX is expected to report earnings on Jul 16, 2025.
GALT is expected to report earnings on Aug 18, 2025.
Industries' Descriptions
@Railroads (+2.33% weekly)The Railroad industry includes passenger and freight transportation services along rail lines. This also includes companies that provide maintenance and switching duties as part of rail services. Within North America, the industry is largely dominated by some large operators. Several short-line railroads serve regional and local routes. Union Pacific Corporation, Canadian National Railway Company, and CSX Corporation are some of the prominent names in the business. The railroad business is relatively cyclical; economic expansion boost the freight services in particular, while economic stagnation often dampens transportation demand.
@Biotechnology (-3.48% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| CSX | GALT | CSX / GALT | |
| Capitalization | 56.9B | 87.2M | 65,252% |
| EBITDA | 6.75B | -40.38M | -16,714% |
| Gain YTD | -10.576 | 6.977 | -152% |
| P/E Ratio | 18.04 | N/A | - |
| Revenue | 14.3B | 0 | - |
| Total Cash | 1.15B | 27.1M | 4,232% |
| Total Debt | 19.6B | 105M | 18,667% |
CSX | GALT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 10 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 43 | 100 | |
SMR RATING 1..100 | 37 | 100 | |
PRICE GROWTH RATING 1..100 | 61 | 63 | |
P/E GROWTH RATING 1..100 | 61 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CSX's Valuation (78) in the Railroads industry is in the same range as GALT (96) in the Biotechnology industry. This means that CSX’s stock grew similarly to GALT’s over the last 12 months.
CSX's Profit vs Risk Rating (43) in the Railroads industry is somewhat better than the same rating for GALT (100) in the Biotechnology industry. This means that CSX’s stock grew somewhat faster than GALT’s over the last 12 months.
CSX's SMR Rating (37) in the Railroads industry is somewhat better than the same rating for GALT (100) in the Biotechnology industry. This means that CSX’s stock grew somewhat faster than GALT’s over the last 12 months.
CSX's Price Growth Rating (61) in the Railroads industry is in the same range as GALT (63) in the Biotechnology industry. This means that CSX’s stock grew similarly to GALT’s over the last 12 months.
CSX's P/E Growth Rating (61) in the Railroads industry is somewhat better than the same rating for GALT (100) in the Biotechnology industry. This means that CSX’s stock grew somewhat faster than GALT’s over the last 12 months.
| CSX | GALT | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 67% | N/A |
| Stochastic ODDS (%) | 4 days ago 62% | 4 days ago 80% |
| Momentum ODDS (%) | 4 days ago 59% | 4 days ago 72% |
| MACD ODDS (%) | 4 days ago 53% | 4 days ago 90% |
| TrendWeek ODDS (%) | 4 days ago 59% | 4 days ago 85% |
| TrendMonth ODDS (%) | 4 days ago 56% | 4 days ago 82% |
| Advances ODDS (%) | 5 days ago 56% | 6 days ago 79% |
| Declines ODDS (%) | 7 days ago 50% | 4 days ago 85% |
| BollingerBands ODDS (%) | 4 days ago 63% | 4 days ago 86% |
| Aroon ODDS (%) | 4 days ago 46% | 4 days ago 89% |
CSX and
Correlation & Price change
A.I.dvisor indicates that over the last year, CSX has been closely correlated with NSC. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if CSX jumps, then NSC could also see price increases.
GALT and
Correlation & Price change
A.I.dvisor indicates that over the last year, GALT has been loosely correlated with BCAB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GALT jumps, then BCAB could also see price increases.
| Ticker / NAME | Correlation To GALT | 1D Price Change % | ||
|---|---|---|---|---|
| GALT | 100% | -1.43% | ||
| BCAB - GALT | 36% Loosely correlated | -9.13% | ||
| SNPX - GALT | 32% Poorly correlated | +0.41% | ||
| RNAC - GALT | 32% Poorly correlated | -4.99% | ||
| NVO - GALT | 31% Poorly correlated | +1.42% | ||
| ERAS - GALT | 27% Poorly correlated | N/A | ||
More | ||||